Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Dedicare Life Science AB
AB
Active
Org 5567676548
Dalagatan 100, 113 43
Stockholm
Temporary employment agency activities and other human resource provisions
·
NACE 7820
Est. 2008 · 17 years old
20-49 employees
Monitor
Share
Sweden
/
Companies
/
Temporary employment agency activities and other human resource provisions
/
Dedicare Life Science AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
70M
52M
35M
17M
0M
2020: 32M
32M
2020
2021: 55M (+72% vs 2020)
55M
+72%
2021
2022: 56M (+2% vs 2021)
56M
+2%
2022
2023: 34M (-39% vs 2022)
34M
-39%
2023
2024: 39M (+15% vs 2023)
39M
+15%
2024
EBITDA
SEK millions
15M
10M
5M
0M
-5M
2020: 7M
7M
2020
2021: 11M (+57% vs 2020)
11M
+57%
2021
2022: 11M (0% vs 2021)
11M
0%
2022
2023: 2M (-82% vs 2022)
2M
-82%
2023
2024: -1M (-150% vs 2023)
-1M
-150%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
38 946
34 017
56 376
54 826
31 831
Staff expenses
—
—
—
—
—
EBITDA
−1 093
2 158
11 377
10 683
6 507
Depreciation & amort.
−0
−0
−9
−19
−14
EBIT
−1 093
2 158
11 368
10 664
6 493
Net financials
233
144
−7
−3
−2
Profit before tax
−215
−162
11 362
10 627
6 491
Tax
−0
−0
−2 370
−2 224
−1 421
Net profit
−215
−162
8 992
8 403
5 070
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
14 254
12 281
17 778
18 114
11 294
Equity
8 715
8 931
9 093
8 503
5 170
Long-term debt
0
0
0
0
0
Short-term debt
5 539
3 350
8 686
9 612
6 124
Total debt
5 539
3 350
8 686
9 612
6 124
Financial ratios
5-year trend
EBITDA margin
−2,8 %
This company
15,8 %
Market median
This company
Market median
118% below market
2020
2024
Equity ratio
61,1 %
This company
38,2 %
Market median
This company
Market median
60% above market
2020
2024
Return on equity
−2,5 %
This company
18,4 %
Market median
This company
Market median
114% below market
2020
2024
Net profit margin
−0,6 %
This company
8,1 %
Market median
This company
Market median
107% below market
2020
2024
Asset turnover
2,73×
This company
1,12×
Market median
This company
Market median
144% above market
2020
2024
Debt / equity
0,64×
This company
0,62×
Market median
This company
Market median
3% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Dedicare Life Science AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
